190 related articles for article (PubMed ID: 32684241)
21. Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening.
Charles MRC; Mahesh A; Lin SY; Hsieh HP; Dhayalan A; Coumar MS
Biochimie; 2020 Jan; 168():220-230. PubMed ID: 31756401
[TBL] [Abstract][Full Text] [Related]
22. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
24. G9a inhibition induced PKM2 regulates autophagic responses.
Ahmad F; Dixit D; Joshi SD; Sen E
Int J Biochem Cell Biol; 2016 Sep; 78():87-95. PubMed ID: 27417236
[TBL] [Abstract][Full Text] [Related]
25. RNA-seq based transcriptome analysis of EHMT2 functions in breast cancer.
Kim K; Ryu TY; Ryu JW; Han TS; Jung CR; Son MY; Kim DS; Cho HS
Biochem Biophys Res Commun; 2020 Apr; 524(3):672-676. PubMed ID: 32033749
[TBL] [Abstract][Full Text] [Related]
26. Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.
Salton M; Voss TC; Misteli T
Nucleic Acids Res; 2014 Dec; 42(22):13662-73. PubMed ID: 25414343
[TBL] [Abstract][Full Text] [Related]
27. EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
Pal A; Leung JY; Ang GCK; Rao VK; Pignata L; Lim HJ; Hebrard M; Chang KT; Lee VK; Guccione E; Taneja R
Elife; 2020 Nov; 9():. PubMed ID: 33252038
[TBL] [Abstract][Full Text] [Related]
28. BIX-01294, a G9a inhibitor, suppresses cell proliferation by inhibiting autophagic flux in nasopharyngeal carcinoma cells.
Li Q; Wang L; Ji D; Bao X; Tan G; Liang X; Deng P; Pi H; Lu Y; Chen C; He M; Zhang L; Zhou Z; Yu Z; Deng A
Invest New Drugs; 2021 Jun; 39(3):686-696. PubMed ID: 33387131
[TBL] [Abstract][Full Text] [Related]
29. Abnormal histone H3K9 dimethylation but normal dimethyltransferase EHMT2 expression in cloned sheep embryos.
Fu L; Zhang J; Yan FX; Guan H; An XR; Hou J
Theriogenology; 2012 Dec; 78(9):1929-38. PubMed ID: 23058792
[TBL] [Abstract][Full Text] [Related]
30. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294.
Imai K; Togami H; Okamoto T
J Biol Chem; 2010 May; 285(22):16538-45. PubMed ID: 20335163
[TBL] [Abstract][Full Text] [Related]
31. Effect of BIX-01294 on H3K9me2 levels and the imprinted gene Snrpn in mouse embryonic fibroblast cells.
Chen P; Yao JF; Huang RF; Zheng FF; Jiang XH; Chen X; Chen J; Li M; Huang HF; Jiang YP; Huang YF; Yang XY
Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26285804
[TBL] [Abstract][Full Text] [Related]
32. Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription.
Huang ZC; Huang J; Huang CK; Hou Y; Zhu B
Kaohsiung J Med Sci; 2023 Jun; 39(6):576-586. PubMed ID: 36825520
[TBL] [Abstract][Full Text] [Related]
33. EHMT2/G9a Inhibits Aortic Smooth Muscle Cell Death by Suppressing Autophagy Activation.
Chen TQ; Hu N; Huo B; Masau JF; Yi X; Zhong XX; Chen YJ; Guo X; Zhu XH; Wei X; Jiang DS
Int J Biol Sci; 2020; 16(7):1252-1263. PubMed ID: 32174799
[TBL] [Abstract][Full Text] [Related]
34. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
[TBL] [Abstract][Full Text] [Related]
35. Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
Thng DKH; Hooi L; Toh CCM; Lim JJ; Rajagopalan D; Syariff IQC; Tan ZM; Rashid MBMA; Zhou L; Kow AWC; Bonney GK; Goh BKP; Kam JH; Jha S; Dan YY; Chow PKH; Toh TB; Chow EK
Mol Oncol; 2023 Nov; 17(11):2275-2294. PubMed ID: 36896891
[TBL] [Abstract][Full Text] [Related]
36. G9a-mediated histone methylation regulates cadmium-induced male fertility damage in pubertal mice.
Li M; Liu C; Yang L; Zhang L; Chen C; He M; Lu Y; Feng W; Pi H; Zhang Y; Zhong M; Yu Z; Zhou Z
Toxicol Lett; 2016 Jun; 252():11-21. PubMed ID: 27060504
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
[TBL] [Abstract][Full Text] [Related]
38. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.
Kubicek S; O'Sullivan RJ; August EM; Hickey ER; Zhang Q; Teodoro ML; Rea S; Mechtler K; Kowalski JA; Homon CA; Kelly TA; Jenuwein T
Mol Cell; 2007 Feb; 25(3):473-81. PubMed ID: 17289593
[TBL] [Abstract][Full Text] [Related]
39. Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy.
Gu M; Toh TB; Hooi L; Lim JJ; Zhang X; Chow EK
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45427-45441. PubMed ID: 31718136
[TBL] [Abstract][Full Text] [Related]
40. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
